Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study

Yoshiya Tanaka, Kiyotaka Yamazaki, Ryo Nakajima, Shuichi Komatsu, Ataru Igarashi, Toshiro Tango, Tsutomu Takeuchi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study'. Together they form a unique fingerprint.

Medicine & Life Sciences